Cathie Wood Recursion Pharmaceuticals, Inc. Transaction History
Ark Investment Management LLC
- $11 Billion
- Q2 2024
A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Ark Investment Management LLC holds 28,142,918 shares of RXRX stock, worth $172 Million. This represents 1.92% of its overall portfolio holdings.
Number of Shares
28,142,918
Previous 24,587,561
14.46%
Holding current value
$172 Million
Previous $245 Million
13.9%
% of portfolio
1.92%
Previous 1.75%
Shares
13 transactions
Others Institutions Holding RXRX
# of Institutions
286Shares Held
236MCall Options Held
985KPut Options Held
2.4M-
Baillie Gifford & CO26.6MShares$162 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$132 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$106 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$94 Million1.74% of portfolio
-
Kinnevik Ab (Publ) Stockholm, V711.9MShares$72.7 Million100.0% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.1B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...